Therefore, we performed a Kaplan–Meier plots to investigate the clinical features between SETD2 SET domain mutation group and non-SET domain mutation group; results indicated that SETD2 SET domain mutation group was featured with advanced tumor stage and poor prognosis in ccRCC (Fig. 4A). Here, SETD2 is linked to nonpapillary renal cell carcinoma.